Hong Kong Commercial Daily Report∣Pharmapack: Based on the Chinese Market While Actively Exploring the Indian and American Markets

On June 2, Pharmapack was invited to an exclusive interview from Hong Kong Commercial Daily, in which Pharmapack's corporate culture, mission and social responsibility were introduced in detail. The report has been published in the Special Report Column of Hong Kong Commercial Daily Guangdong Branch. If you are interested, you can read the report by scanning the QR code below.

Now I'd like to share with you the original text for those who pay close attention to Pharmapack

[Hong Kong Commercial Daily News] Reporter/Huang Yuyong: As one of the key industries in Guangzhou, there are many industry-leading companies in the robot and intelligent equipment industry. Among them, Pharmapack Technologies Corporation, as an important member of the Guangzhou Industrial Robot Manufacturing and Application Industry Alliance and a Hong Kong-funded enterprise, is the "leader" of China's pharmaceutical packaging machinery industry, firmly occupying the highest position in the domestic high-end manufacturing and packaging machinery industry. According to Pharmapack's Director and Chief Financial Officer Wang Jue, Pharmapack will actively explore the Indian and American Markets to expand its global business after deeply digging into China's market.

Pharmapack Technologies Corporation is a successful example of scientific and technological cooperation between Guangzhou and Hong Kong in the manufacturing field. Pharmapack Asia Ltd. was founded in 2001, focusing on the development, design, manufacturing, installation and commissioning of pharmaceutical packaging equipment and after-sales service. In October 2002, Pharmapack (Guangzhou) Packaging Equipment Co., Ltd. was established in Guangzhou Economic and Technological Development Zone, dedicated to providing high cost-effective packaging equipment and complete packaging production lines for the pharmaceutical industry. Wang Jue said that the company has become a leader in the high-end pharmaceutical packaging machinery industry in China. 

01 Winning the leading position in the industry with scientific and technological innovation

To become the industry leader, mastering the core technologies is the key. Wang Jue told reporters that Pharmapack now owns more than 200 patents, including more than 20 invention patents, and has formulated 5 national industry standards in China.

At present, the R&D and Design Center and Production and Manufacturing Base in Guangzhou Economic and Technological Development Zone adopt international advanced technical standards and provide users with production equipment with excellent performance and quality under the support of international procurement networks.

"We have gained a firm foothold in the Chinese market," said Wang Jue. At present, Pharmapack is based in the Chinese mainland market, with branches in Beijing, Shanghai, Guangzhou, Chengdu and Wuhan as the centers, and sales service points in Shenyang, Jinan, Changsha, Xi'an, etc. as the support, covering the nationwide sales and after-sales service network.The construction of Guangdong-Hong Kong-Macao Greater Bay Area has provided a broader development space for Pharmapack. Wang Jue revealed that the company will take advantage of the opportunity of building a world-class Greater Bay Area to attract high-end talent who are familiar with Chinese and Western cultures, strengthen the company's industrial design capability, and prepare to be listed on the Science and Technology Innovation Board.

02 Expanding the Indian and American markets with personalized products

In the global manufacturing and packaging machinery industry, China, India and the United States account for 60% of the global market share. After its performance in the Chinese market is stable, Pharmapack has a strong demand for international expansion. At present, Pharmapack's business in China and beyond China accounts for 60% and 40% respectively, but according to the company's strategic planning, the proportion of its international business will rise to 70% in the next 5 years.

Compared with its global competitors, Pharmapack not only has certain technical advantages, but also has good product cost performance, which is an important guarantee for competing in the international market. In addition, Pharmapack has the ability to manufacture products that can meet the individual needs of customers, which is far ahead of its counterparts abroad.

It is reported that Pharmapack has established a product life cycle management model that runs through product conceptual design, R&D, engineering design, manufacturing, installation and commissioning, and after-sales service, which not only ensures the unified standards of the industry and the clear requirements of users, but also ensures the potential needs of users' personalized requirements and subsequent technical improvement of products in use, thus establishing a product development mechanism that continuously meets the needs of customers.

In the Indian market, Pharmapack has established cooperation with the top 5 local manufacturers to provide them with high cost-effective pharmaceutical packaging machinery products.

The United States is undoubtedly another focus and huge market of Pharmapack's global strategy. At present, Pharmapack has also established a wholly-owned subsidiary in the US market. Facing the possible tariff burden caused by China-US trade friction, Wang Jue believes that Pharmapack will consider setting up an assembly workshop in the United States as a countermeasure, which can not only increase its production capacity, but also provide customers with fast delivery service. "We will not rule out the establishment of a production base in the United States in the future," she said.

[Editor-in-Charge: Zhao Shuqi]